Skip to main navigation menu Skip to main content Skip to site footer


Vol. 146 No. 3940 (2016)

Young blood for old hands? A recent anti-ageing trial prompts ethical questions

  • Nikola Biller-Andorno
Cite this as:
Swiss Med Wkly. 2016;146:w14359


  1. Werner M. Bis bald (See you soon). Frankfurt a.M.: Fischer, 2011.
  2. Federal Office of Public Health (FOPH): Confederation and cantons take action against providers of illegal fresh cell therapy. Media release, March 26, 2015.
  3. Eggel A, Wyss-Coray T. A revival of parabiosis in biomedical research. Swiss Med Wkly. 2014;144:w13914.
  4. Villeda SA, Plambeck EK, Middeldorp J, Castellano JM, Moshere KI, LuoJ, et al. Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nature. 2014;477:90–4.
  5. Shytikov D, Balva O, Debonneuil E, Glukhovskiv P, Pishel I. Aged mice repeatedly injected with plasma from young mice: a survival study. Biores Open Access. 2014;3(5):226–32. doi: 10.1089/biores.2014.0043.
  6. Kaiser J. Antiaging trial using young blood stirs concerns. Science. 2016;353:527–8.
  7. Scudellari M. Ageing research: Blood to blood. Nature 2015;517:426–9, doi:10.1038/517426a.
  8. Schulz-Baldes A, Biller-Andorno N, Capron A. International perspectives on the ethics and regulation of human cell and tissue transplantation. World Health Bulletin. 2007;85(12):941–8.
  9. Thompson JJ. A defense of abortion. Philosophy & Public Affairs. 1971;1(1):47–66.